Pricing Log in Create free account

Boundless Bio, Inc. (BOLD) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Boundless Bio, Inc. and Corbus Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Boundless Bio, Inc. and Corbus Pharmaceuticals Holdings, Inc. are of similar size ($55.3M and $54.8M). Across the 8 metrics below, Boundless Bio, Inc. leads on 7 and Corbus Pharmaceuticals Holdings, Inc. on 1.

Valuation

Metric BOLD CRBP Biotechnology median
P/E n/m n/m 10.60
P/S n/m 38.44 9.40
P/B 0.83 0.58 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.34 0.66
EV/Sales n/m (23.77) 9.02
Earnings yield (116.73%) (202.95%) (32.88%)
Free cash flow yield (103.14%) (146.45%) (23.13%)

Profitability

Metric BOLD CRBP Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.86%) (95.58%) (51.96%)
Return on assets (50.56%) (80.85%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BOLD CRBP Biotechnology median
Revenue growth (TTM) — (73.69%) 6.76%
EPS growth (last fiscal year) 32.47% (60.33%) 29.88%
Revenue growth, 5-year CAGR — (14.34%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BOLD CRBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.48 5.71 4.97
Net debt to EBITDA 0.99 1.90 1.01

Dividend

Metric BOLD CRBP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLD CRBP Biotechnology median
Market cap 54.83m 55.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack